We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Engineering the Future of Genetic Medicine

Industry Insight   Mar 31, 2021

Engineering the Future of Genetic Medicine

Scribe Therapeutics leadership team. Pictures from left to right: Pictured from left to right: Benjamin Oakes, Co-founder, President and CEO Brett Staahl, Co-founder and VP of Platform Svetlana Lucas, Chief Business Officer Jennifer Doudna, Co-founder and Scientific Advisor David Savage, Co-founder and Scientific Advisor. Credit: Scribe Therapeutics.

 
 
Advertisement
 
 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE